Jane Street
YARW

Jane Street’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Jane Street’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed -$79K – 7642
2020
Q1 		$79K Buy
+8
New +$125K ﹤0.01% 5005

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street's YARW Position: Q1 2026 in Review

Jane Street increased its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 32% in Q1 2026, buying an estimated $13.6K and bringing the position to 1,913 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #10916.

Jane Street first reported a position in YARW in Q1 2020 and has held it in 13 quarters since. The position peaked at $206K in Q2 2025. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Jane Street held 1,913 shares of Yarrow Bioscience, Inc. Common Stock worth $57.1K as of Q1 2026.
  • Jane Street bought 466 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $13.6K.
  • Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10916 holding.
  • Jane Street first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and has held it in 13 quarters since.
  • Jane Street's Yarrow Bioscience, Inc. Common Stock position peaked at $206K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.